论文部分内容阅读
目的探讨糖化血红蛋白(HbA1c)与空腹血糖(FPG)联合检测在糖尿病控制中的作用,为糖尿病治疗提供合理的监测方案。方法采用免疫比浊法测定HbA1c,氧化酶法测定FPG。结果糖尿病患者的HbA1c和FPG与正常对照组相比,差异有统计学意义(P<0.05)。结论 HbA1c能准确反映糖尿病患者体内糖代谢与病情控制程度,是评价糖尿病近期控制状况的灵敏而可靠指标,联合检测HbA1c与FPG具有重要的临床价值。
Objective To investigate the role of combined detection of HbA1c and fasting plasma glucose (FPG) in the control of diabetes and to provide a reasonable monitoring program for the treatment of diabetes mellitus. Methods Immunoturbidimetry was used to determine HbA1c and oxidase method to determine FPG. Results There was significant difference between HbA1c and FPG in diabetic patients and normal controls (P <0.05). Conclusion HbA1c can accurately reflect the degree of glycometabolism and disease control in patients with diabetes mellitus, which is a sensitive and reliable indicator to evaluate the recent control of diabetes. Combined detection of HbA1c and FPG has important clinical value.